Mono Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Mononucleosis, Endemic Burkitts lymphoma, Hodgkins lymphoma, Gastric carcinomas, Multiple sclerosis, Nasopharyngeal, Carcinoma); End user (Adults, Children), and Geography

Report Code: TIPRE00021901 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Mono, also known as mononucleosis, is an infectious disease caused by the Epstein-Barr virus. Since this virus is transmitted primarily by saliva, it is also known as kissing disease. Other methods of transmission include exchanging drinks or utensils. Mono/kissing disease is caused by the Epstein-Barr virus, also known as human herpesvirus 4. The Epstein-Barr virus is the most common type of virus in humans, and it is one of eight types of human herpes virus family. Various companies are focusing on novel monovaccine research and development, which may spur industry players' interest in conducting research and development in this field of high unmet need. Currently, there is no approved Mono vaccine in the market.

MARKET DYNAMICS

Factors driving the growth of the mono vaccine market are the growing government initiatives, coupled with rising healthcare spending. However, the number of barriers in the development and gaining approval for EBV vaccines is expected to hamper the growth of the market. Moreover, increasing research and development activities by pharmaceutical companies is anticipated to boost the market growth.

MARKET SCOPE

The "Mono Vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of mono vaccine market with detailed market segmentation by application and end user. The mono vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in mono vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The mono vaccine market is segmented on the basis of application and end user. On the basis of application, the market is categorized as mononucleosis, Endemic Burkitt's Lymphoma, Hodgkin's Lymphoma, gastric carcinomas, multiple sclerosis, and nasopharyngeal carcinoma. On the basis of end-user, the market is categorized as adults and children

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the mono vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mono vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting mono vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mono vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the mono vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from mono vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for mono vaccine in the global market. Below mentioned is the list of few companies engaged in the mono vaccine market.

The report also includes the profiles of key players in mono vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   GlaxoSmithKline plc
  •   Sanofi S.A.
  •   Pfizer Inc
  •   CNBG
  •   Merck
  •   Neuron Biotech
  •   MSD
  •   Serum Institute of India
  •   Biomed Pvt. Ltd
  •   Baxter International

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mono Vaccine Market - By Application
1.3.2 Mono Vaccine Market - By End user
1.3.3 Mono Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MONO VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MONO VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MONO VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MONO VACCINE - GLOBAL MARKET OVERVIEW
6.2. MONO VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MONO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. MONONUCLEOSIS
7.3.1. Overview
7.3.2. Mononucleosis Market Forecast and Analysis
7.4. ENDEMIC BURKITT'S LYMPHOMA
7.4.1. Overview
7.4.2. Endemic Burkitt's lymphoma Market Forecast and Analysis
7.5. HODGKIN'S LYMPHOMA
7.5.1. Overview
7.5.2. Hodgkin's lymphoma Market Forecast and Analysis
7.6. GASTRIC CARCINOMAS
7.6.1. Overview
7.6.2. Gastric carcinomas Market Forecast and Analysis
7.7. MULTIPLE SCLEROSIS
7.7.1. Overview
7.7.2. Multiple sclerosis Market Forecast and Analysis
7.8. NASOPHARYNGEAL
7.8.1. Overview
7.8.2. Nasopharyngeal Market Forecast and Analysis
7.9. CARCINOMA
7.9.1. Overview
7.9.2. Carcinoma Market Forecast and Analysis
8. MONO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. ADULTS
8.3.1. Overview
8.3.2. Adults Market Forecast and Analysis
8.4. CHILDREN
8.4.1. Overview
8.4.2. Children Market Forecast and Analysis
9. MONO VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mono Vaccine Market Overview
9.1.2 North America Mono Vaccine Market Forecasts and Analysis
9.1.3 North America Mono Vaccine Market Forecasts and Analysis - By Application
9.1.4 North America Mono Vaccine Market Forecasts and Analysis - By End user
9.1.5 North America Mono Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mono Vaccine Market
9.1.5.1.1 United States Mono Vaccine Market by Application
9.1.5.1.2 United States Mono Vaccine Market by End user
9.1.5.2 Canada Mono Vaccine Market
9.1.5.2.1 Canada Mono Vaccine Market by Application
9.1.5.2.2 Canada Mono Vaccine Market by End user
9.1.5.3 Mexico Mono Vaccine Market
9.1.5.3.1 Mexico Mono Vaccine Market by Application
9.1.5.3.2 Mexico Mono Vaccine Market by End user
9.2. EUROPE
9.2.1 Europe Mono Vaccine Market Overview
9.2.2 Europe Mono Vaccine Market Forecasts and Analysis
9.2.3 Europe Mono Vaccine Market Forecasts and Analysis - By Application
9.2.4 Europe Mono Vaccine Market Forecasts and Analysis - By End user
9.2.5 Europe Mono Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mono Vaccine Market
9.2.5.1.1 Germany Mono Vaccine Market by Application
9.2.5.1.2 Germany Mono Vaccine Market by End user
9.2.5.2 France Mono Vaccine Market
9.2.5.2.1 France Mono Vaccine Market by Application
9.2.5.2.2 France Mono Vaccine Market by End user
9.2.5.3 Italy Mono Vaccine Market
9.2.5.3.1 Italy Mono Vaccine Market by Application
9.2.5.3.2 Italy Mono Vaccine Market by End user
9.2.5.4 Spain Mono Vaccine Market
9.2.5.4.1 Spain Mono Vaccine Market by Application
9.2.5.4.2 Spain Mono Vaccine Market by End user
9.2.5.5 United Kingdom Mono Vaccine Market
9.2.5.5.1 United Kingdom Mono Vaccine Market by Application
9.2.5.5.2 United Kingdom Mono Vaccine Market by End user
9.2.5.6 Rest of Europe Mono Vaccine Market
9.2.5.6.1 Rest of Europe Mono Vaccine Market by Application
9.2.5.6.2 Rest of Europe Mono Vaccine Market by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mono Vaccine Market Overview
9.3.2 Asia-Pacific Mono Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mono Vaccine Market
9.3.5.1.1 Australia Mono Vaccine Market by Application
9.3.5.1.2 Australia Mono Vaccine Market by End user
9.3.5.2 China Mono Vaccine Market
9.3.5.2.1 China Mono Vaccine Market by Application
9.3.5.2.2 China Mono Vaccine Market by End user
9.3.5.3 India Mono Vaccine Market
9.3.5.3.1 India Mono Vaccine Market by Application
9.3.5.3.2 India Mono Vaccine Market by End user
9.3.5.4 Japan Mono Vaccine Market
9.3.5.4.1 Japan Mono Vaccine Market by Application
9.3.5.4.2 Japan Mono Vaccine Market by End user
9.3.5.5 South Korea Mono Vaccine Market
9.3.5.5.1 South Korea Mono Vaccine Market by Application
9.3.5.5.2 South Korea Mono Vaccine Market by End user
9.3.5.6 Rest of Asia-Pacific Mono Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Mono Vaccine Market by Application
9.3.5.6.2 Rest of Asia-Pacific Mono Vaccine Market by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mono Vaccine Market Overview
9.4.2 Middle East and Africa Mono Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mono Vaccine Market
9.4.5.1.1 South Africa Mono Vaccine Market by Application
9.4.5.1.2 South Africa Mono Vaccine Market by End user
9.4.5.2 Saudi Arabia Mono Vaccine Market
9.4.5.2.1 Saudi Arabia Mono Vaccine Market by Application
9.4.5.2.2 Saudi Arabia Mono Vaccine Market by End user
9.4.5.3 U.A.E Mono Vaccine Market
9.4.5.3.1 U.A.E Mono Vaccine Market by Application
9.4.5.3.2 U.A.E Mono Vaccine Market by End user
9.4.5.4 Rest of Middle East and Africa Mono Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Mono Vaccine Market by Application
9.4.5.4.2 Rest of Middle East and Africa Mono Vaccine Market by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mono Vaccine Market Overview
9.5.2 South and Central America Mono Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Mono Vaccine Market Forecasts and Analysis - By Application
9.5.4 South and Central America Mono Vaccine Market Forecasts and Analysis - By End user
9.5.5 South and Central America Mono Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mono Vaccine Market
9.5.5.1.1 Brazil Mono Vaccine Market by Application
9.5.5.1.2 Brazil Mono Vaccine Market by End user
9.5.5.2 Argentina Mono Vaccine Market
9.5.5.2.1 Argentina Mono Vaccine Market by Application
9.5.5.2.2 Argentina Mono Vaccine Market by End user
9.5.5.3 Rest of South and Central America Mono Vaccine Market
9.5.5.3.1 Rest of South and Central America Mono Vaccine Market by Application
9.5.5.3.2 Rest of South and Central America Mono Vaccine Market by End user
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MONO VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MONO VACCINE MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI S.A.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CNBG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NEURON BIOTECH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MSD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SERUM INSTITUTE OF INDIA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIOMED PVT. LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BAXTER INTERNATIONAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc
2. Sanofi S.A.
3. Pfizer Inc
4. CNBG
5. Merck
6. Neuron Biotech
7. MSD
8. Serum Institute of India
9. Biomed Pvt. Ltd
10. Baxter International
11. Biokangtai
12. JN-International Medical Corporation
TIPRE00021901
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking